Dye & Durham Plans C$52 Million Convertible Debenture Buyback
By Robb M. Stewart
Dye & Durham has moved to pay down up to 52 million Canadian dollars ($39.3 million) of its debt as part of an effort to bolster its balance sheet over time, offering to buy back issued and outstanding 3.75% convertible senior secured debentures due March 1, 2026.
The offering will be funded from cash on hand and is above the debt cutting Dye & Durham has said it plans using the proceeds from the sale of its TM Group subsidiary in the U.K. to German alternative investment firm Aurelius.
The offer is expected to proceed by way of a modified Dutch auction, which will allow debenture holders who choose to participate to select the price, within a range, to tender their debentures. Dye & Durham said it is making the offer at between C$500 and C$650 per C$1,000 of debenture face value.
Last week, the provider of cloud-based legal practice management software said it surpassed C$100 million in annual recurring revenue, which it regards as a key marker of scale that positions it for growth.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
July 24, 2023 07:41 ET (11:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
After Earnings, Is Coinbase Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
Is ServiceNow Stock a Buy After Earnings and Its Investor Day?
-
3 Stocks to Buy and 3 Stocks to Sell After Earnings
-
Today’s Market Volatility Could Provide Tomorrow’s Opportunities
-
40 of the Best Investment Picks
-
Tech Stock Dividends Are Changing the Face of Dividend Growth Investing
-
Roblox Earnings: Weakening Engagement Has Weighed On Growth
-
The Best Gaming Stocks to Buy
-
Energy Transfer Earnings: M&A Drives Guidance Increase In Solid Quarter
-
The Best Healthcare Stocks to Buy
-
Going Into Earnings, Is Home Depot Stock a Buy, a Sell, or Fairly Valued?